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Background/aim: Caffeic acid phenethyl ester (CAPE) and Ankaferd Blood Stopper (ABS) are considered to contribute to wound
healing. The purpose of this study was to investigate the effect of ABS and CAPE on secondary wound healing of oral mucosal tissue.
Materials and methods: In total, 63 male Sprague-Dawley rats were used in this study. The animals were randomly divided into three
groups and anaesthetized with ketamine (8 mg/100 g, intraperitoneally): a control group, CAPE group, and ABS group. A full-thickness
excisional wound was created using a 4 mm punch biopsy tool. Topical ABS and CAPE were then applied in each group for 7, 14,
and 21 days (n = 7 in each group). The animals in each group were sacrificed after 7, 14, and 21 days. Palatal specimens were stained
with haematoxylin-eosin. Vascular endothelial growth factor (VEGF) and tumour necrosis factor-inducible gene 6 (TSG-6) protein
expressions were determined using the Western blot method.
Results: Inflammation, vessel dilatation, and haemorrhages were significantly lower in the CAPE group as compared with these
parameters in the other groups (P < 0.05). Fibrosis was significantly higher in the ABS group as compared with that in the other groups
(P < 0.05). VEGF protein levels were elevated in the 21-day CAPE group and 7-day ABS group. The expression of TSG-6 increased in
the 7-day CAPE group and 21-day ABS group.
Conclusion: Based on our findings, ABS and CAPE had positive effects on the oral wound healing process.
Key words: Wound healing, vascular endothelial growth factor, tumour necrosis factor-inducible gene 6 protein

1. Introduction
The wound healing process consists of four highly
connected and overlapping processes: haemostasis,
inflammation, proliferation, and tissue remodelling
[1]. These stages and their biophysiological functions
take place in a specific sequence, at a particular time,
and for a specific period at an optimal intensity [2].
Many factors can affect wound healing and interfere
with one or more phases of the wound healing process,
leading to incomplete tissue repair [3]. After periodontal
surgery, both bacterial contamination and plaque control
affect the success of the surgery. Therapeutic agents are
used to reduce bacterial plaque accumulation, prevent
postoperative pain and tissue oedema, and accelerate
wound healing [4].
Ankaferd Blood Stopper (ABS) is a plant extract that is
widely used as a haemostatic agent in Turkey. ABS consists
of Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum,
Urtica dioica, and Thymus vulgaris [5]. Previous research

demonstrated the effectiveness of ABS in bleeding
control, as well as its strong antimicrobial properties [6].
According to a previous study, the haemostatic activity
and antimicrobial properties of ABS suggest that it may
be useful in dental treatments [7].
Caffeic acid phenethyl ester (CAPE) is an active
component of propolis, which is a compound produced
by bees from substances that the bees collect from
plants. Propolis-based products are used in the cosmetic
industry, as well as in the therapeutic field, primarily for
their antibacterial and antiinflammatory effects, and the
therapeutic properties of propolis are well accepted [8].
Considering the reported beneficial effects of ABS
and CAPE, it is reasonable to speculate that they might
accelerate the healing process of mucosal wounds [7,8].
Therefore, the aim of the present study was to investigate
the effects of topical ABS and CAPE on secondary healing
of the surfaces of experimental excisional wound areas
created in the palatal mucoperiosteum of rats.
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2. Materials and methods
Sixty-three male Sprague-Dawley rats (mean age: 7 weeks;
weight: 280–490 g) were used in this study. The study was
conducted at the Health Institution Research Centre, Dicle
University, Diyarbakır, Turkey (ethics committee approval
no: 2015/17).
The rats were housed individually in plastic cages in a
controlled environment (21 °C and a 12 h light/12 h dark
cycle), with free access to drinking water and food. They
were randomly divided into three groups and anaesthetized
with ketamine (8 mg/100 g, intraperitoneally): control
group, CAPE group, and ABS group. Palatal mucosal
defects were created in the three groups. The rats in the
ABS group were topically treated with 0.10 mL of ABS
solution, and the rats in the CAPE group were topically
treated with 100 mmol/kg of CAPE. Pressure was applied
to a sterile pad until bleeding control was achieved. All
treatments were applied for 7, 14, and 21 days (n = 7).
2.1. Creation of palatal mucosal defects
Prior to the creation of palatal mucosal defects (4 mm),
intramuscular ketamine HCl (Alfamine 10%; Alfasan,
Woerden, the Netherlands) at a dose of 45 mg/kg and
xylazine HCl (Alfazyne 2%; Alfasan) at a dose of 2.50
mg/kg were administered. The rats were prepared for
the surgical procedure in accordance with standard
disinfection and sterilization guidelines, and the surgery
was performed using sterile instruments. A 4-mm punch
biopsy instrument was used to create a full-thickness
excisional wound area between the molar teeth.
After the surgical procedure, the wound areas were
allowed to recover (i.e., secondary healing). All the rats
in each group were sacrificed by a single dose of sodium
thiopentone (lethal dose: 60 mg/kg) administered
intraperitoneally. Palatal tissue specimens, including the
tissue around the wound site area, were obtained. The
tissues were stored in 10% formaldehyde for histological
evaluation. For biochemical analysis, the tissues taken
with the punch biopsy were stored in Eppendorf tubes at
–80 °C until the time of the analysis.
2.2. Histopathological method
The palatal specimens were fixed directly in neutral
buffered formalin fixative. After complete fixation of
the tissues, they were washed under running water
for 12 h. The specimens were dehydrated through a
graded alcohol series (30%, 50%, 70%, 80%, 90%, 96%,
and 100%) for 12 h, followed by immersion in xylene,
infiltration, and embedding in paraffin blocks. Sections of
paraffin-embedded tissues 5 µm thick were stained with
haematoxylin-eosin dye and placed on poly-L-lysinecoated slides. They were placed in an incubator at 60 °C
overnight. After the sections had cooled, they were cleared
in xylene three times for 2–5 min, followed by passing
through 96%, 80%, 70%, and 60% ethyl alcohol for 5 min.

They were placed in distilled water for 5 min. The sections
were placed in EDTA solution to dissolve the palatal tissue.
The sections were mounted on slides. They were placed in
citric acid (pH 6) for 7 + 5 min to remove antigen masking.
They were cooled for 20 min at room temperature, washed
with phosphate-buffered saline (PBS) solution (3 × 5
min), and placed in 3% hydrogen peroxide for 20 min for
endogenous peroxide blockade. The sections were washed
again with PBS (3 × 5 min) and placed in an incubation
container. All subsequent procedures were carried out in
this incubation container.
Vascular endothelial growth factor (VEGF) (mouse
monoclonal, sc-7269, Santa Cruz Biotechnology, USA)
and tumour necrosis factor-inducible gene 6 (TSG-6)
(mouse monoclonal, sc-65886, Santa Cruz Biotechnology)
antibodies were applied to the sections. The primary
antibody was applied for 1 h and washed with PBS
solution (3 × 5 min). The secondary antibody (Zymed
and Histostain-Plus Kit; Invitrogen) was marked with
streptavidin and dripped and left for 30 min in the closed
moist box, followed by washing with PBS solution (3 × 5
min). Aminoethyl carbazole was used as a chromogen.
This step was followed by washing with distilled water to
prevent the reaction of the antigen/antibody. Following
contrast staining with Mayer’s haematoxylin, the samples
were washed in distilled water again. In the final stage,
for immunohistopathological analysis, the sections were
evaluated using a photomicroscope (Nikon Eclipse i50;
Nikon, Tokyo, Japan) for blind evaluation.
2.3. Western blotting method
2.3.1. Cell lysis and protein quantitation
The palatal tissue was frozen in liquid nitrogen and
powdered in a porcelain mortar. The powdered placental
tissue (50 mg) was placed in 250 μL of RIPA lysis solution
containing a protease inhibitor mixture in ice for 1 h. The
lysed placental samples were stored at –86 °C. All the steps
were performed on ice to prevent protein degradation. The
total cellular protein concentration was calculated using a
Pierce BCA Kit (Thermo Scientific, Waltham, MA, USA).
2.3.2. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
The protein samples were prepared in SDS loading
solution (2% SDS, 5% glycerol, 0.01% bromophenol
blue, and 8% DL-dithiothreitol) and boiled at 95 °C for 5
min. The protein samples (20 μg) were loaded into a 10%
polyacrylamide gel, and electrophoresis was performed
using buffer solution (2.40 mm Tris, 19.20 mm glycine,
and 0.01% SDS) for 1 h at 200 V.
2.3.3. Membrane transfer and antibody staining of proteins
The separated proteins were transferred from SDS-PAGE
to a PVDF membrane at 100 V. The membrane was
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blocked at room temperature for 1 h and 5% milk powder
prepared in PBS solution. The membrane was treated
with primary antibodies at room temperature for 2 h,
followed by washing four times with PBS-T for 30 min.
Subsequently, the membrane was treated with horseradish
peroxidase-conjugated secondary antibodies at room
temperature for 1 h at a 1:10,000 dilution rate. Finally, the
membrane was washed again four times with PBS for 30
min. Protein bands were visualized using an enhanced
chemiluminescent reagent chemical (Bio-Rad, Hercules,
CA, USA).
2.4. Statistical analysis
The power of the study was calculated as 80% on the
epithelial regeneration of the palatal oral mucosa of rats
used in the experiment. The effect size was 0.5 and the
α value was taken as 0.05. Sample size estimation was
performed by using G*Power (Franz Faul, University of
Kiel, Kiel, Germany) version 3.1.9.2. Statistical analysis
of the data was performed using the SPSS version 21.0
for Windows (IBM Corp., Armonk, NY, USA) statistical
program. The histological data and numerical values are
shown as mean (mean) and standard deviation. The Mann–
Whitney U test was used for comparisons of two groups.
A Bonferroni-corrected Mann–Whitney U test was used
for comparisons of more than two groups. In all statistical
tests, a value of P < 0.05 was considered significant.
3. Results
3.1. Histopathological findings
In the 7-day ABS group, small vacuous structures were
observed, with mild hypertrophy of basal cells. Connective
tissue and collagen fibres were clearly observed (Figure
1A). In the 7-day CAPE group, mitotic activity in the
germinal epithelium increased, and mononuclear cells were
individually scattered in connective tissue (Figure 1B). In
the 7-day control group, the basal cells were prismatic in
appearance, and collagen fibres were arranged in a parallel
fashion in connective tissue. In addition, connective tissue
cells were distributed freely, and the vascular structure
appeared normal (Figure 1C).
The 14-day ABS group was characterized by
hyperplasia in the basal cells, in addition to hypertrophy
of spinosum cells. Small clusters of connective tissue and
mononuclear cell infiltration were also observed (Figure
1D). In the 14-day CAPE group, numerous cylindrical cells
were observed in the basal layer, and secondary papillary
structures were detected in the epithelium. Collagen fibres
and vascular structure were also visible (Figure 1E). In
the 14-day control group, the basal cells were prismatic
in appearance, and collagen fibres of connective tissue
were arranged in a parallel fashion. Connective tissue cells
were scattered freely, and the vascular structure appeared
normal (Figure 1F).
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In the 21-d ABS group, hyperplasia was present in the
basal cells, and small groups of mononuclear cells were
visible in connective tissue (Figure 1G). In the 21-day
CAPE group, there was an increase in mitotic activity in
the germinal epithelium and inflammatory cells in some
connective tissue areas (Figure 1H). In the control group,
the basal cells were prismatic in appearance, and collagen
fibres were arranged in a parallel manner in connective
tissue. In addition, connective tissue cells were freely
distributed, and the vascular structure appeared normal
(Figure 1I).
3.2. Immunohistochemical findings of TSG-6
In the 7-day ABS group, a TSG-6-positive reaction was
observed in small numbers of inflammatory cells in the
small vessels of connective tissue (Figure 2A). In the 7-day
CAPE group, TSG-6 expression was positive in polygonal
cells in the spinosum layer, and the TSG-6 reaction was
positive in a few cells in connective tissue (Figure 2B).
In the 7-day control group, TSG-6 was not expressed in
epithelial cells, and weak TSG-6 expression was detected
in cells in the papillary region and deep connective tissue
areas (Figure 2C).
In the 14-day ABS group, TSG-6-positive cells were
observed in small vessels in connective tissue and in a
few inflammatory cells (Figure 2D). TSG-6-positive cells
were also detected in some basal cells in the 14-day CAPE
group and in a small number of vascular cells (Figure 2E).
In the 14-day control group, TSG-6 was not expressed in
epithelial cells, and weak TSG-6 expression was observed
in cells in the papillary region and deep connective tissue
areas (Figure 2F).
In the 21-day ABS group, TSG-6-positive expression
was observed in a small number of cells in the papillary
area and macrophages in connective tissue (Figure 2G).
TSG-6-positive expression was also observed in the basal
membrane structure of blood vessels in the 21-day CAPE
group (Figure 2H). In the 21-day control group, TSG-6
was not expressed in epithelial cells, and weakly expressed
in cells in the papillary region and deep connective tissue
(Figure 2I).
3.3. Immunohistochemical findings of VEGF
In the 7-day ABS group, a VEGF-positive reaction was
observed in diffuse connective tissue cells in connective
tissue areas, in addition to weak expression in vascular
endothelial cells (Figure 3A). VEGF was not expressed
in blood vessels and connective tissue in the 7-day CAPE
group (Figure 3B). Weak VEGF expression was observed
in vascular endothelial cells and connective cells in the
7-day control group (Figure 3C).
In the 14-day ABS group, VEGF was not expressed
in endothelial cells in vessel walls (Figure 3D). A VEGFpositive reaction was observed in a small number of
inflammatory cells around the vessels in the 14-d CAPE
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Figure 1. A) 7th day ABS group; haematoxylin-eosin staining bar 20 µm. B) 7th day CAPE group; haematoxylin-eosin staining bar 50
µm. C) 7th day control group; haematoxylin-eosin staining bar 100 µm. D) 14th day ABS group; haematoxylin-eosin staining bar 20
µm. E) 14th day CAPE group; haematoxylin-eosin staining bar 20 µm. F) 14th day control group; haematoxylin-eosin staining bar 100
µm. G) 21st day ABS group; haematoxylin-eosin staining bar 20 µm. H) 21st day CAPE group; haematoxylin-eosin staining bar 20 µm.
I) 21st day control group; haematoxylin-eosin staining bar 100 µm.

group (Figure 3E). Poor VEGF expression was observed in
vascular endothelial cells and connective cells in the 14-d
control group (Figure 3F).
In the 21-day ABS group, VEGF was not expressed in
endothelial cells in blood vessels, whereas a VEGF-positive
reaction was observed in mononuclear cells, which were
sparsely distributed in connective tissue (Figure 3G).
VEGF expression was not detected in blood vessels and
connective tissue of the 21-day CAPE group (Figure
3H). Poor VEGF expression was observed in vascular
endothelial cells and connective cells in the 21-day control
group (Figure 3I).
3.4. Results of the statistical analysis of the three groups
We evaluated whether epithelium regeneration, fibrosis,
inflammation, vascular dilatation, and haemorrhages had a
significant effect on wound healing, with these parameters
assigned values between 0 and 4.

Tables 1, 2, and 3 present data on the mean of the
histopathological values of the rats on days 7, 14, and 21,
respectively. The tables show the mean values for epithelium
regeneration, fibrosis, inflammation, vascular dilatation,
and haemorrhages in the groups, in addition to the findings
in the ABS group versus the control group, control group
versus the CAPE group, and ABS group versus the CAPE
group. As shown in Table 1, inflammation decreased
significantly in the CAPE group versus the control group
and in the ABS group versus the CAPE group (P < 0.05). In
addition, vascular dilatation and haemorrhages decreased
significantly in the ABS and CAPE groups as compared
with these parameters in the control group (P < 0.05). As
presented in Table 2, fibrosis increased significantly in the
control group as compared with that in the ABS group.
In the comparison between ABS group and CAPE group,
fibrosis decreased significantly (P < 0.05). There was no
statistically significant difference in any other parameters

251

GÜL et al. / Turk J Med Sci

Figure 2. A) 7th day ABS group; TSG-6 immunostaining bar 100 µm. B) 7th day CAPE group; TSG-6 immunostaining bar 50 µm. C)
7th day control group; TSG-6 immunostaining bar 100 µm. D) 14th day ABS group; TSG-6 immunostaining bar 100 µm. E) 14th day
CAPE group; TSG-6 immunostaining bar 100 µm. F) 14th day control group; TSG-6 immunostaining bar 100 µm. G) 21st day ABS
group; TSG-6 immunostaining bar 50 µm. H) 21st day CAPE group; TSG-6 immunostaining bar 100 µm. I) 21st day control group;
TSG-6 immunostaining bar 100 µm.

between the other groups. As shown in Table 3, epithelial
regeneration decreased significantly in the ABS group
versus the CAPE group (P < 0.05). Vascular dilatation and
haemorrhages increased significantly in the control group
as compared with that in the CAPE group (P < 0.05). There
were no statistically significant differences in any other
parameters between the groups.
3.5. Results of the biochemical analysis
In the 7-day ABS group and 21-day CAPE group,
the expression of VEGF in palatal tissue increased
dramatically (Figure 4). TSG-6 expression in palatal tissue
also markedly increased in the 7-day CAPE group and 21day ABS group (Figure 5).
4. Discussion
Many factors have an adverse effect on wound healing
at various stages of the wound healing process, thereby
impairing tissue production and impeding wound healing
[9].
In a previous study, Kosger et al. induced 10 mm fullthickness palatal mucosal wounds in rats and then applied
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Arnebia densiflora extract topically to the surface of the
wounds. The rats were sacrificed 4, 7, 14, and 21 days later,
and palatal tissue specimens were evaluated histologically
[10]. Tramontina et al. investigated the effect of bismuth
subgallate on wound healing in rats in which a 3.50 × 2
mm wound was created. They performed a histological
and morphological analysis 1, 4, 7, 11, and 18 days
later [11]. Kozlovsky et al. studied the effects of various
antimicrobial agents on wound healing of a soft tissue
defect with a diameter of 5 mm in the palatal mucosa of
rats [12]. Yamashita et al. used the rat palatal space as an
experimental wound healing model to assess the impact of
zoledronate on bone and mucosal wounds [13]. Koluman
et al. suggested that the concentrations of the antioxidants
and other specific molecules in ABS have not been affected
after exposure to the synthetic gastric fluid. Those findings
have provided the basis for future ABS clinical trials that
will be designed for the oral-systemic administration to
control haemorrhages of the gastrointestinal system tract
[14]. Sezgin et al. excisional wounds with a diameter of 3
mm were made in the centre of the palatal mucosa and they
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Figure 3. A) 7th day ABS group; VEGF immunostaining bar 100 µm. B) 7th day CAPE group; VEGF immunostaining bar 100 µm. C)
7th day control group; VEGF immunostaining bar 100 µm. D) 14th day ABS group; VEGF immunostaining bar 100 µm. E) 14th day
CAPE group; VEGF immunostaining bar 100 µm. F) 14th day control group; VEGF immunostaining bar 100 µm. G) 21st day ABS
group; VEGF immunostaining bar 100 µm. H) 21st day CAPE group; VEGF immunostaining bar 100 µm. I) 21st day control group;
VEGF immunostaining bar 100 µm.

determined the number of subjects of each group to be 7
[15]. Ersel et al. evaluated in vivo wound healing effects of
a sericin-containing gel formulation in an incision wound
model in rats and they determined the number of subjects
of each group to be 7 [16].
In the present study, we created an excisional wound
model in rat palatal mucosa and then evaluated secondary
healing. We determined the number of subjects of each
group to be 7. In our study, tissue samples were obtained 7,
14, and 21 days after CAPE and ABS treatment to evaluate
the effects of CAPE and ABS on wound healing in oral
mucosal tissue of rats. Before the study, a preliminary
evaluation was undertaken to determine the ideal defect
width for histological and biochemical evaluations. Based
on this evaluation and to standardize the excisional
surgery, a full-thickness defect with a diameter of 4 mm
was created by punch biopsy.
According to Demiralp et al., ABS inhibited the
growth of bacteria, as well as haemostatic activity. Given
the antiinfective effect of ABS, it may be useful in the

clinical setting, for example, in the treatment of traumatic
wounds. Thus, it is important to determine its effectiveness
against various pathogens [17]. In the present study, vessel
dilatation and haemorrhages decreased in the 7-day ABS
group. This finding suggested that in the early stage of
wound healing, ABS may reduce bleeding by forming
a protein network and consequently decrease the side
effects of bacterial infection in a wound. It may also reduce
inflammation, thereby exerting a positive effect on wound
healing.
A recent study on ABS-treated defects observed a
reduction in wound width and an increase in wound
contraction. The authors attributed these findings to
an increase in the rate of healing and a reduction in
inflammation due to the antioxidant activity of the
components in ABS [18]. Yüce et al. suggested that on days
5–10, the inflammatory granulation tissue in the ABStreated wounds was less than in the normal wounds. By day
30, all of the wounds had achieved the same symptomatic
state [19]. In the present study, we observed no positive
effects of ABS on wound inflammation at 7, 14, or 21-days.
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Table 1. Comparison of histopathological values at day 7.
Control
n=7

ABS
n=7

CAPE
n=7

Kruskal–Wallis
P-value

Mann–Whitney
U P- value

Epithelium regeneration

0.57 ± 0.53

0.86 ± 0.69

0.71 ± 0.49

0.689

NS*, NS**, NS***

Fibrosis

1 ± 0.58

0.71 ± 0.76

1 ± 0.58

0.585

NS*, NS**, NS***

Inflammation

1.29 ± 0.76

1.29 ± 0.76

0.29 ± 0.49

0.027

NS*, 0.020**, 0.020***

Vascular dilatation and haemorrhage

1.43 ± 0.54

0.71 ± 0.49

0.71 ± 0.49

0.035

0.030*, 0.030** NS***

*ABS group comparison with control group (P < 0.05); **Comparison of control group with CAPE group (P < 0.05); ***Comparison of
ABS group with CAPE group (P < 0.05), NS: Not significant.
Table 2. Comparison of histopathological values at day 14.
Control
n=7

ABS
n=7

CAPE
n=7

Kruskal–Wallis
P- value

Mann–Whitney
U P- value

Epithelium regeneration

1.00 ± 0.58

1.29 ± 0.76

0.57 ± 0.54

0.136

NS*, NS** NS***

Fibrosis

0.57 ± 0.54

2.71 ± 0,49

1.14 ± 0.69

0.001

0.001*, NS** 0.003***

Inflammation

1.14 ± 0.69

1.14 ± 0.69

0.57 ± 0.54

0.184

NS*, NS** NS***

Vascular dilatation and haemorrhage

0.86 ± 0.69

0.86 ± 0.69

0.71 ± 0.49

0.910

NS*, NS** NS***

*ABS group comparison with control group (P < 0.05), **Comparison of control group with CAPE group (P < 0.05), ***Comparison of
ABS group with CAPE group (P < 0.05), NS: Not significant.
Table 3. Comparison of histopathological values at day 21.
Control
n=7

ABS
n=7

CAPE
n=7

Kruskal–Wallis
P-value

Mann–Whitney
U P-value

Epithelium regeneration

0.86 ± 0.69

1.43 ± 0.54

0.57 ± 0.54

0.052

NS*, NS** 0.018***

Fibrosis

0.57 ± 0.54

0.86 ± 0.69

1.00 ± 0.58

0.405

NS*, NS** NS***

Inflammation

0.43 ± 0.54

0.71 ± 0.49

0.43 ± 0.54

0.483

NS*, NS** NS***

Vascular dilatation and haemorrhage

0.57 ± 0.54

1.00 ± 0.58

1.29 ± 0.49

0.073

NS*, 0.030** NS***

*ABS group comparison with control group (P < 0.05), **Comparison of control group with CAPE group (P < 0.05), ***Comparison of
ABS group with CAPE group (P < 0.05), NS: Not significant.

Reepithelization occurs in the proliferative phase of
wound healing due to stimulation of growth factors, which
are synthesized and secreted by platelets and macrophages
[20]. Epithelial cells, which extend toward the edge of a
wound, are the basic elements of wound healing, starting
from the edge of the wound as a result of migration from
the central membrane toward the base of the wound [21].
In the present study, increased epithelial regeneration,
with positive effects on wound healing, was observed in
the 7, 14, and 21-day ABS groups, although the increase
in epithelial regeneration was not statistically significant.
In a rat study, Ögetürk et al. created soft tissue damage
using carbon tetrachloride (CCl4) and applied CAPE
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to the wound. They observed no pathology in a control
group, but the epithelium was reduced and pulmonary
interstitium haemorrhages were detected in the CCl4
group. In addition, they observed polymorphous core
leukocytes and macrophage infiltration. In the CCl4
CAPE-treated group, they observed mild haemorrhage
areas similar to the control group [22].
In the present study, vessel dilatation and haemorrhages
were decreased in the 7-day CAPE group. We speculate
that CAPE may exert a positive effect on wound healing by
decreasing bleeding and inflammation. In the 14-day CAPE
group, vessel dilatation and haemorrhages decreased, but
the reduction was not statistically significant. In the 21-

GÜL et al. / Turk J Med Sci

Figure 4. Twenty µg total protein gel was run. Anti-VEGF and anti-β-actin antibodies were analysed
using the western blotting method. β-actin was used as loading control.

Figure 5. Twenty µg total protein gel was run. Anti-TSG-6 and anti-β-actin antibodies were analysed
using the western blotting method. β-actin was used as loading control.

day CAPE group, vessel dilatation and haemorrhages
increased significantly as compared with these parameters
in the control group. These findings may be attributed to
the loss of antiinflammatory and haemostatic activity of
CAPE in the later wound healing period.
Previous research reported that CAPE exhibited
strong antioxidant, antiinflammatory, and wound healing
properties, with the latter attributed to the effect of CAPE
on nuclear factor-κB inhibition [23]. In previous in vitro
and in vivo studies, CAPE was applied at micromolar
concentrations. During inflammation, arachidonic acid
showed various biological activities, such as suppression of
the lipoxygenase pathway and inhibition of nuclear factorκB [24]. Magro-Filho and De Carvalho demonstrated that
topical applications of CAPE to wound surfaces in oral
cavity surgery reduced inflammation and had an analgesic
effect [25]. In the present study, inflammation decreased
significantly in the 7-day CAPE group. Although
inflammation also improved in the 14-day CAPE group,
the improvement was not statistically significant. There
was no reduction in inflammation in the other groups. The
positive effects of CAPE on wound healing may be due to
its antiinflammatory effects and antimicrobial properties.
Özyurt et al. reported that CAPE was superior to E-vit in
preventing bleomycin-induced lung fibrosis. CAPE also

reduced hydroxyproline, malondialdehyde (MDA), and
myeloperoxidase (MPO) levels as compared with those
in a control group, although the E-vit treatment was most
successful [26].
In the present study, fibrosis decreased in rats in
the 7-day CAPE group, although this finding was not
statistically significant as compared with that in the
other groups. Fibrous tissue is undesirable in wound
healing. We think that CAPE likely had a positive effect
on hydroxyproline, MDA, and MPO. Fibrosis increased in
the 14- and 21-day CAPE groups as compared with that
in the control group, but the finding was not statistically
significant. By 14 and 21 days, wound healing had
accelerated, at which point fibrous tissue formation was
undesirable. Based on these results, CAPE appeared to
have positive effects on the early stage of wound healing
by enhancing the wound healing rate. These effects can
be attributed to the antimicrobial and antiinflammatory
properties of CAPE.
Lopes-Rocha et al. reported that propolis had a
beneficial effect on surgical wound healing in the oral
cavity. In their study, CAPE reduced inflammation and
granulation and accelerated the formation of tissue
formation and epithelization [27]. In the present study,
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CAPE increased epithelium regeneration and had positive
effects on wound healing on day 7, and it decreased
epithelial regeneration on days 14 and 21. These findings
indicate that these positive effects of CAPE decreased in
the late period of wound healing. Furthermore, CAPE had
a positive effect on the wound healing mechanism.
Getting et al. found that TSG-6 reduced the level of
inflammatory mediators: Tumour necrosis factor-alpha
(TNF-α) and prostaglandin-E2 (PGE2) [28]. Beltran et al.
suggested that after an intragingival injection of TSG-6,
infiltration of neutrophils and proinflammatory cytokines
as well as signs of inflammation decreased at 2 weeks [29].
In a study on rats in which corneal mechanical injury was
induced, a TSG-6 injection into the anterior cavities of
the rats’ eyes reduced corneal infection and inflammation
[30]. In the current study, TSG-6 expression was low in the
ABS group and control group but markedly increased in
the CAPE group. These findings show that both CAPE and
ABS had positive impacts on wound healing. The latter is
likely to be due to the antiinflammatory and antimicrobial
properties of CAPE and ABS.
According to one study, VEGF was particularly
effective in terms of angiogenesis, epithelization, and
collagen accumulation [31]. In the current study, VEGF
expression was detected in the 7-day ABS group. This
finding showed that ABS had a positive effect on wound

healing by increasing vascularization. In the present study,
VEGF was not expressed in the control group on day 21,
whereas it was expressed on day 21 in the ABS group.
VEGF expression increased in the 21-day CAPE group.
In conclusion, in this study, the effects of ABS and
CAPE on secondary healing of experimentally generated
excisional wounds in the palatal mucosa of rats were
evaluated histologically and biochemically. ABS was
successful as a local haemostatic agent. CAPE was a
biocompatible agent with oral mucosal tissues. ABS and
CAPE appear to have a positive effect on reepithelization
in the early stage of wound healing. ABS and CAPE may
be beneficial in wound healing in periodontal surgery.
Studies on postoperative and long-term results following
the application of ABS and CAPE are needed to shed light
on their clinical effects on wound healing in mucosal
healing.
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